TL44: Statistical Modeling to Evaluate Long-Term Persistence
*Jason Martin, Merck & Co., Inc. 


This session intends to discuss the methods used to evaluate long term persistence in vaccines. Discussion will include various statistical models that were developed to evaluate the long-term persistence and the duration of protection after receipt of vaccine.